Annual ROE
-29.77%
-4.69%-18.70%
December 31, 2021
Summary
- As of February 10, 2025, CLBS annual return on equity is -29.77%, with the most recent change of -4.69% (-18.70%) on December 31, 2021.
- During the last 3 years, CLBS annual ROE has risen by +13.08% (+30.53%).
Performance
CLBS ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly ROE
-65.67%
-38.50%-141.70%
September 1, 2022
Summary
- As of February 10, 2025, CLBS quarterly return on equity is -65.67%, with the most recent change of -38.50% (-141.70%) on September 1, 2022.
- Over the past year, CLBS quarterly ROE has dropped by -35.52% (-117.81%).
Performance
CLBS Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
CLBS ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -18.7% | -117.8% |
| 3 y3 years | +30.5% | -16.6% |
| 5 y5 years | -165.4% | -191.9% |
CLBS ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | +167.1% | at low |
| 5 y | 5-year | +18.7% | +212.4% | +187.9% | +24.1% |
| alltime | all time | -102.7% | +6859.0% | -101.2% | +5585.5% |
Caladrius Biosciences ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -65.67%(+141.7%) |
| Jun 2022 | - | -27.17%(+10.5%) |
| Mar 2022 | - | -24.59%(-9.1%) |
| Dec 2021 | -29.77%(+18.7%) | -27.05%(-10.3%) |
| Sep 2021 | - | -30.15%(-12.2%) |
| Jun 2021 | - | -34.34%(+50.5%) |
| Mar 2021 | - | -22.81%(-15.1%) |
| Dec 2020 | -25.08%(-73.0%) | -26.88%(-4.0%) |
| Sep 2020 | - | -28.01%(-6.1%) |
| Jun 2020 | - | -29.84%(-63.4%) |
| Mar 2020 | - | -81.48%(+16.4%) |
| Dec 2019 | -93.01%(+117.1%) | -69.97%(+24.3%) |
| Sep 2019 | - | -56.31%(+21.5%) |
| Jun 2019 | - | -46.34%(+17.2%) |
| Mar 2019 | - | -39.55%(+2.8%) |
| Dec 2018 | -42.85%(-194.2%) | -38.46%(+12.5%) |
| Sep 2018 | - | -34.20%(+7.6%) |
| Jun 2018 | - | -31.78%(-159.0%) |
| Mar 2018 | - | 53.86%(-8.1%) |
| Dec 2017 | 45.50%(-106.8%) | 58.60%(-18.0%) |
| Sep 2017 | - | 71.43%(-25.1%) |
| Jun 2017 | - | 95.40%(-116.6%) |
| Mar 2017 | - | -575.13%(+55.6%) |
| Dec 2016 | -668.65%(+239.9%) | -369.60%(-16.4%) |
| Sep 2016 | - | -442.26%(+69.7%) |
| Jun 2016 | - | -260.54%(+48.2%) |
| Mar 2016 | - | -175.77%(+10.6%) |
| Dec 2015 | -196.74%(+117.0%) | -158.95%(+57.5%) |
| Sep 2015 | - | -100.94%(-1.6%) |
| Jun 2015 | - | -102.58%(+5.2%) |
| Mar 2015 | - | -97.51%(+14.4%) |
| Dec 2014 | -90.66%(+11.3%) | -85.27%(-8.6%) |
| Sep 2014 | - | -93.33%(+5.0%) |
| Jun 2014 | - | -88.89%(-10.5%) |
| Mar 2014 | - | -99.34%(-1.0%) |
| Dec 2013 | -81.45%(-27.9%) | -100.31%(-13.9%) |
| Sep 2013 | - | -116.55%(+7.6%) |
| Jun 2013 | - | -108.31%(-10.2%) |
| Mar 2013 | - | -120.67%(+13.6%) |
| Dec 2012 | -112.96%(+32.6%) | -106.21%(+9.2%) |
| Sep 2012 | - | -97.29%(+6.9%) |
| Jun 2012 | - | -91.04%(+28.8%) |
| Mar 2012 | - | -70.68%(-6.2%) |
| Dec 2011 | -85.17%(+32.6%) | -75.33%(+29.7%) |
| Sep 2011 | - | -58.07%(-8.2%) |
| Jun 2011 | - | -63.24%(+3.9%) |
| Mar 2011 | - | -60.89%(+2.4%) |
| Dec 2010 | -64.23% | -59.47%(-41.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2010 | - | -101.46%(-29.0%) |
| Jun 2010 | - | -142.81%(-45.7%) |
| Mar 2010 | - | -262.76%(-47.9%) |
| Dec 2009 | -211.26%(-52.2%) | -504.21%(-75.9%) |
| Sep 2009 | - | -2094.97%(+184.7%) |
| Jun 2009 | - | -735.81%(-1.7%) |
| Mar 2009 | - | -748.32%(+59.6%) |
| Dec 2008 | -442.29%(-23.6%) | -468.91%(+33.8%) |
| Sep 2008 | - | -350.53%(-30.9%) |
| Jun 2008 | - | -507.39%(+0.2%) |
| Mar 2008 | - | -506.18%(-10.9%) |
| Dec 2007 | -579.00%(-72.1%) | -567.82%(-17.1%) |
| Sep 2007 | - | -685.28%(-61.6%) |
| Jun 2007 | - | -1786.30%(-52.2%) |
| Mar 2007 | - | -3733.67%(-170.9%) |
| Dec 2006 | -2071.69%(-2257.8%) | 5267.04%(+616.9%) |
| Sep 2006 | - | 734.70%(+241.2%) |
| Jun 2006 | - | 215.31%(+56.4%) |
| Mar 2006 | - | 137.69%(+71.8%) |
| Dec 2005 | 96.01%(+6.1%) | 80.13%(+16.5%) |
| Sep 2005 | - | 68.78%(-4.9%) |
| Jun 2005 | - | 72.36%(-11.0%) |
| Mar 2005 | - | 81.29%(-14.5%) |
| Dec 2004 | 90.51%(+30.3%) | 95.09%(-13.3%) |
| Sep 2004 | - | 109.64%(+13.1%) |
| Jun 2004 | - | 96.93%(+5.2%) |
| Mar 2004 | - | 92.17%(+10.5%) |
| Dec 2003 | 69.48%(-50.6%) | 83.39%(-7.0%) |
| Sep 2003 | - | 89.70%(-22.3%) |
| Jun 2003 | - | 115.44%(-27.5%) |
| Mar 2003 | - | 159.27%(-50.3%) |
| Dec 2002 | 140.77%(-197.7%) | 320.17%(-136.2%) |
| Sep 2002 | - | -885.44%(+198.1%) |
| Jun 2002 | - | -297.07%(+64.9%) |
| Mar 2002 | - | -180.17%(+27.5%) |
| Dec 2001 | -144.02%(+97.3%) | -141.26%(+49.3%) |
| Sep 2001 | - | -94.59%(-1.7%) |
| Jun 2001 | - | -96.24%(+20.6%) |
| Mar 2001 | - | -79.78%(+35.2%) |
| Dec 2000 | -73.00%(-8.5%) | -59.01%(+76.5%) |
| Sep 2000 | - | -33.44%(+191.8%) |
| Jun 2000 | - | -11.46%(+213.1%) |
| Mar 2000 | - | -3.66% |
| Dec 1999 | -79.79%(-154.9%) | - |
| Dec 1998 | 145.42%(-86.8%) | - |
| Mar 1998 | 1099.58%(+2054.3%) | - |
| Mar 1997 | 51.04%(-109.5%) | - |
| Mar 1996 | -536.23% | - |
FAQ
- What is Caladrius Biosciences annual return on equity?
- What is the all time high annual ROE for Caladrius Biosciences?
- What is Caladrius Biosciences annual ROE year-on-year change?
- What is Caladrius Biosciences quarterly return on equity?
- What is the all time high quarterly ROE for Caladrius Biosciences?
- What is Caladrius Biosciences quarterly ROE year-on-year change?
What is Caladrius Biosciences annual return on equity?
The current annual ROE of CLBS is -29.77%
What is the all time high annual ROE for Caladrius Biosciences?
Caladrius Biosciences all-time high annual return on equity is 1099.58%
What is Caladrius Biosciences annual ROE year-on-year change?
Over the past year, CLBS annual return on equity has changed by -4.69% (-18.70%)
What is Caladrius Biosciences quarterly return on equity?
The current quarterly ROE of CLBS is -65.67%
What is the all time high quarterly ROE for Caladrius Biosciences?
Caladrius Biosciences all-time high quarterly return on equity is 5267.04%
What is Caladrius Biosciences quarterly ROE year-on-year change?
Over the past year, CLBS quarterly return on equity has changed by -35.52% (-117.81%)